• By ICR Secretariat
  • Posted Monday, July 5, 2021

AZ doses first participants with COVID-19 variant vaccine

http://www.pharmatimes.com/news/az_doses_first_participants_with_covid-19_variant_vaccine_1372293

AstraZeneca (AZ) has announced that the first participants have been vaccinated as part of a Phase II/III trial testing a new COVID-19 variant vaccine – AZD2816.